Kimberly A. Brown, MD

Liver Lineup: Updates & Unfiltered Insights

 — an exciting new podcast delivering timely, candid perspectives on the most pressing topics in the fast-moving world of 

. Created by Nancy Reau, MD, and Kimberly Brown, MD, and hosted by 

, this series dives into the cutting edge of liver disease research, clinical care, and real-world practice.

Intended for hepatologists, gastroenterologists, and other clinicians managing liver disease, 

 will unpack the latest research, debate emerging controversies, and spotlight developments that could shape — or sharpen — day-to-day practice, all with unfiltered perspective and clarity.

Brown is division chief of gastroenterology and hepatology and the Associate Medical Director of the Henry Ford Hospital Transplant Institute at Henry Ford Hospital. She is also a Professor of Medicine at Wayne State University

Reau is a professor of internal medicine, the Richard B. Capps Chair of Hepatology, Associate Director of Solid Organ Transplantation, and the section chief of Hepatology at Rush University Medical Center.

In the inaugural episode, Brown and Reau introduce the mission behind 

and share why they created the podcast. Driven by a shared commitment to education, clinical excellence, and elevating the conversation around liver disease, the hosts describe their hope to offer practicing clinicians a clear, concise, and engaging way to keep up with the latest news and innovations in hepatology. They aim to highlight data that’s not only new, but meaningful — spotlighting developments that can improve patient care today and shape best practices tomorrow.

Together, the Brown and Reau set the stage for what’s to come: expert commentary on major liver meetings including Digestive Disease Week, European Association for the Study of the Liver Congress, The Liver Meeting from the American Association for the Study of Liver Diseases, and the American College of Gastroenterology Annual Meeting; coverage of key topics like MASLD, liver cancer, viral hepatitis, and transplant; and conversations with colleagues across the hepatology spectrum. From debates over practice-changing data to discussions on care pathways and diagnostics, 

 aims to keep clinicians informed, engaged, and ready to translate insight into impact.

Looking ahead, Brown and Reau preview upcoming episodes covering major hepatology updates from Digestive Disease Week 2025 and European Association for the Study of the Liver Congress 2025 — with more to follow throughout the year.

Editors’ note: Relevant Disclosures for 

 include AbbVie, Gilead, Salix, Arbutus, and VIR. Relevant disclosures for 

 include Mallinckrodt Pharmaceuticals, Gilead, Salix, Intercept, Ipsen, and Madrigal.

Podcasts

Liver Lineup: Updates & Unfiltered Insights is a hepatology podcast from HCPLive hosted by Nancy Reau, MD, and Kimberly Brown, MD, exploring the latest news and research in liver disease.

Refractory Encephalopathy, Multivitamins and Closing Thoughts 

What is the recommendation on multivitamins and supplements in patients with chronic liver disease?

How frequent is refractory encephalopathy?

Videos

Medical experts share insights on managing refractory hepatic encephalopathy and provide concluding remarks and essential points on the condition. 

Practical Tips for the Primary Care Clinician Treating HE

In a busy primary care practice taking on the care of patients with HE can be challenging and overwhelming, what are some clinical pearls/ resources/ and advice that you have for the primary care clinician?

The group of hepatic encephalopathy (HE) professionals acknowledges the challenges and potential overwhelm faced by busy primary care practices when managing patients with HE, and they provide practical clinical pearls and advice to support these clinicians in delivering effective care and improving patient outcomes. 

Practical Tips for the Primary Care Clinician Treating HE  

Managing Adverse Effects in HE Treatment

How do you manage a patient on lactulose and rifaximin who develops diarrhea or a UTI in the outpatient setting?

Medical experts discuss the management of patients with hepatic encephalopathy (HE) receiving   lactulose and rifaximin therapy and develop diarrhea or a urinary tract infection (UTI) in the outpatient setting. 

Kimberly A. Brown, MD

Articles